Stocks
Novartis (NVS) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 321.1% | 321.1% | 374.2% | 374.2% | 413.0% | 310.9% | |||
| Changes by years, y/y, % | -26pp | 0pp | +53pp | 0pp | +39pp | +8.8% | |||
Novartis. R&D/CAPEX, %
Novartis. R&D/CAPEX, changes, pp
Novartis (NVS) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 594.5% | 253.6% | 574.7% | 327.8% | 192.9% | 310.9% | ||
| Changes by years, y/y, % | +324pp | -175pp | +105pp | -50pp | -402pp | |||
| Changes by quarters, q/q, % | +217pp | -341pp | +321pp | -247pp | -135pp | |||
